Literature DB >> 9344654

Mouse chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens.

C F Fletcher1, H J Okano, D J Gilbert, Y Yang, C Yang, N G Copeland, N A Jenkins, R B Darnell.   

Abstract

The paraneoplastic neurologic disorders (PND) are a rare group of neurologic syndromes that arise when an immune response to systemic tumors expressing neuronal proteins ("onconeural antigens") develops into an autoimmune neuronal degeneration. The use of patient antisera to clone the genes encoding PND antigens has led to new insight into the mechanism of these autoimmune disorders. The tumor antigens can now be grouped into three classes: (1) neuron-specific RNA-binding proteins, (2) nerve terminal vesicle-associated proteins, and (3) cytoplasmic signaling proteins. To understand better the evolutionary relatedness of these genes and to evaluate them as candidates for inherited neurological disorders, we have determined the mouse chromosomal locations of nine of these genes-Hua, Hub, Huc, Hud, Nova1, Nova2, Natpb, Cdr2, and Cdr3. These data suggest that the Hua-Hud genes arose from gene duplication and dispersion, while the other genes are dispersed in the genome. We also predict the chromosomal locations of these genes in human and discuss the potential of these genes as candidates for uncloned mouse and human mutations. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344654     DOI: 10.1006/geno.1997.4925

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family.

Authors:  A B Sørensen; A H Lund; S Ethelberg; N G Copeland; N A Jenkins; F S Pedersen
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells.

Authors:  Kevin J O'Donovan; Jennifer Diedler; Graeme C Couture; John J Fak; Robert B Darnell
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

3.  The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia.

Authors:  Y Y Yang; G L Yin; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

4.  The mouse ADP-ribosylation factor-like 4 gene: two separate promoters direct specific transcription in tissues and testicular germ cell.

Authors:  S Jacobs; A Schürmann; W Becker; T M Böckers; N G Copeland; N A Jenkins; H G Joost
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

Review 5.  The neuronal splicing factor Nova controls alternative splicing in N-type and P-type CaV2 calcium channels.

Authors:  Summer E Allen; Robert B Darnell; Diane Lipscombe
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

Review 6.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

7.  Analysis of structural diversity in wolf-like canids reveals post-domestication variants.

Authors:  Oscar Ramirez; Iñigo Olalde; Jonas Berglund; Belen Lorente-Galdos; Jessica Hernandez-Rodriguez; Javier Quilez; Matthew T Webster; Robert K Wayne; Carles Lalueza-Fox; Carles Vilà; Tomas Marques-Bonet
Journal:  BMC Genomics       Date:  2014-06-12       Impact factor: 3.969

8.  NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression.

Authors:  Xin Yu; Heyi Zheng; Matthew T V Chan; William K K Wu
Journal:  J Cell Mol Med       Date:  2018-03-02       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.